Maedica · 2026
The Prevalence and Risk of Polycystic Ovarian Syndrome (PCOS) in Women with Epilepsy: a Systematic Review and Meta-Analysis.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shahraki Zahra, Rastkar Mohsen, Rastkar Elnaz, Mohamadi Aida, Ghajarzadeh Mahsa
Аннотация
BACKGROUND: Women with epilepsy suffer from a wide range of endocrine dysfunctions such as polycystic ovarian syndrome (PCOS). The literature shows various prevalence rates of PCOS in women with epilepsy/seizures. So, we designed this study to estimate the pooled prevalence of PCOS in women with epilepsy/seizures.
METHODS: PubMed, Scopus, EMBASE, Web of Science and Google Scholar were systematically searched by two independent researchers on March 1st 2023.
RESULTS: A literature search revealed 1377 records, of which 120 full-texts were evaluated and finally, 28 studies remained for the present systematic review. Most studies were from India, followed by Finland and Italy. A total of 2587 cases with epilepsy and 607 controls were evaluated. Studies were published between 1984 and 2022. The estimated pooled prevalence of PCOS in women with epilepsy was 19% [95% confidence interval (CI) 14-23%] (I2=91.7%, p<0.001). The estimated odds ratio of PCOS in women with epilepsy was 3.07 (95% CI 1.94-4.85) (I2=43.6%, p=0.07). The estimated prevalence of PCOS in women treated with valproic acid (VAL) was 32% (95% CI 20-45%) (I2=87.9%, P<0.001).
CONCLUSION: The results of this systematic review show that the pooled prevalence of PCOS in women with epilepsy is 19% and the risk of developing PCOS is three-fold higher than in healthy women.
METHODS: PubMed, Scopus, EMBASE, Web of Science and Google Scholar were systematically searched by two independent researchers on March 1st 2023.
RESULTS: A literature search revealed 1377 records, of which 120 full-texts were evaluated and finally, 28 studies remained for the present systematic review. Most studies were from India, followed by Finland and Italy. A total of 2587 cases with epilepsy and 607 controls were evaluated. Studies were published between 1984 and 2022. The estimated pooled prevalence of PCOS in women with epilepsy was 19% [95% confidence interval (CI) 14-23%] (I2=91.7%, p<0.001). The estimated odds ratio of PCOS in women with epilepsy was 3.07 (95% CI 1.94-4.85) (I2=43.6%, p=0.07). The estimated prevalence of PCOS in women treated with valproic acid (VAL) was 32% (95% CI 20-45%) (I2=87.9%, P<0.001).
CONCLUSION: The results of this systematic review show that the pooled prevalence of PCOS in women with epilepsy is 19% and the risk of developing PCOS is three-fold higher than in healthy women.